3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
291
Carcinoma, Non-Small-Cell Lung
206
Prostatic Neoplasms
158
Lung Neoplasms
93
Stomach Neoplasms
69
Neoplasms
69
Head and Neck Neoplasms
60
Squamous Cell Carcinoma of Head and Neck
56
Neoplasm Metastasis
50
Esophageal Neoplasms
49
Ovarian Neoplasms
39
Pancreatic Neoplasms
26
Sarcoma
23
Carcinoma, Ovarian Epithelial
20
Urinary Bladder Neoplasms
19
Unspecified Adult Solid Tumor, Protocol Specific
19
Breast Neoplasms, Male
17
Adenocarcinoma Of Esophagus
17
Parkinson Disease 4, Autosomal Dominant Lewy Body
16
Esophageal Squamous Cell Carcinoma
16
Adenocarcinoma of Lung
16
Fallopian Tube Neoplasms
14
Carcinoma, Squamous Cell
14
Adenocarcinoma
12
Melanoma
11
Inflammatory Breast Neoplasms
11
Uterine Cervical Neoplasms
9
Triple Negative Breast Neoplasms
9
Salivary Gland Neoplasms
8
Endometrial Neoplasms
8
Interventions
Radiotherapy
2
Hydroxyurea
2
Fluorouracil
2
Cisplatin
2
Referral and Consultation
1
Etoposide
1
Erlotinib Hydrochloride
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Docetaxel
1
Chemoprevention
1
Cetuximab
1
Celecoxib
1
Behavior Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Paranasal Sinus Neoplasms
×
Docetaxel
×
Clear all
NCT00117572
2018-04-09
DeCIDE
University of Chicago
Phase 3
Completed
285 enrolled
22 charts